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Abstract
Purpose Sufficient 25-hydroxyvitamin D (25(OH)D) concentrations might prevent a decline in physical performance, and 
are considered important for the prevention of frailty. This study investigates the association of serum 25(OH)D concentra-
tion with physical performance and frailty status in Dutch older adults.
Methods This cross-sectional study included 756 men and women, aged ≥ 65 years. Serum 25(OH)D concentration and 
frailty status (Fried criteria) were assessed in the total population. Screening for frailty status included functional tests of gait 
speed and hand grip strength. In a subgroup (n = 494), the Timed Up and Go test (TUG) and knee-extension strength were 
measured. Associations of serum 25(OH)D status with physical performance were examined by multiple linear regression. 
Prevalence ratios (PR) were used to quantify associations between serum 25(OH)D deficiency (< 50 nmol/L) and frailty.
Results In total, 45% of the participants were vitamin D deficient. Participants with vitamin D status < 50 and 50–75 nmol/L 
had significantly lower scores on the TUG and gait speed test, compared to participants with vitamin D status > 75 nmol/L. 
No significant associations with serum 25(OH)D concentrations were observed for handgrip strength or knee-extension 
strength. Participants with serum 25(OH)D status < 50 nmol/L were about two times more likely to be frail compared to 
participants with serum 25(OH)D status ≥ 50 nmol/L. No significant associations were observed between the pre-frail state 
and serum 25(OH)D status.
Conclusion In this study, serum 25(OH)D concentrations were significantly associated with frailty status and measures of 
physical performance, including gait speed and TUG, but not with strength-related outcomes.
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Introduction
Frailty is a geriatric syndrome associated with adverse 
health outcomes, such as physical disability, increased risk 
of falls, institutionalization, hospitalization and mortality 
[1]. To identify older people at risk, Fried et al. proposed 
a characterization of a frail state, using a clinical pheno-
type [2]. The definition consists of five physical compo-
nents (weakness, slow walking speed, exhaustion, physi-
cal inactivity, and unintentional weight loss) and is now 
commonly applied in clinical research. The prevalence 
of frailty is relatively high among community-dwelling 
elderly, with 44% of seniors being pre-frail, and 10% being 
frail [3]. In view of the ageing population, the prevalence 
of the frailty syndrome will increase, which in turn will 
result in higher rates of hospitalization, and consider-
ably burden the public health care costs [4]. As such, the 
need for interventions, supporting older people to remain 
healthy and independent, increases. One of the key fea-
tures of frailty is profound muscle weakness and a decline 
in functional capabilities [2]. The cause of this loss in 
strength and function is multifactorial, and a low vitamin 
D status is suggested to be one of the risk factors [5, 6]. 
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Vitamin D stimulates calcium absorption in the intestine 
and is responsible for the mineralization of bone and gen-
eral functioning of cells throughout the body [7]. Deficient 
vitamin D concentrations [serum 25(OH)D < 50 nmol/L] 
[8] are common in frail older adults, with a prevalence 
reported up to 62% [9]. Low vitamin D concentrations 
have been associated with an impaired muscle function 
and an increased risk of being frail [9–11]. However, the 
strength and shape of these associations, and the ability 
to control for confounding factors differs between studies. 
Further characterization of the association between serum 
25(OH)D concentration and frailty, but also the closely 
related functional parameters, might help to define con-
sensus about the optimal vitamin D status for these health 
outcomes. Therefore, the aim of this study was to deter-
mine the association of serum 25(OH)D concentrations 
with physical performance and frailty status.
Methods
Study sample
In this study, we report data of 756 older adults that 
attended a screening visit for participation in the 
D-DOSE or D-FIT trial (clinicaltrial.gov registration: 
NCT01868945 or NCT02349282). These studies used 
similar recruitment strategies, inclusion criteria and 
measurement protocols, which allowed combining of 
datasets. Both studies were performed by the Division 
of Human Nutrition, Wageningen University, the Nether-
lands. Recruitment took place via university databases of 
volunteers and municipality registers of Wageningen and 
surroundings, inviting older adults ≥ 65 years to visit the 
study center to screen for eligibility to participate in one of 
the two trials. Details on eligibility criteria of the trials are 
described on clinicaltrial.gov. Participants were scheduled 
for the screening visit if they were 65 years or older and 
were interested to participate in the intervention study. In 
case people were not able to independently travel to the 
study center, a pick-up service was arranged. Visits took 
place between May 2013 and April 2015. During the vis-
its, data on general characteristics, serum 25(OH)D status 
and frailty criteria (gait speed, handgrip strength, physical 
activity, weight loss and self-reported exhaustion) were 
collected in all participants. The screening protocol of the 
D-FIT trial (NCT02349282) contained additional meas-
ures of muscle strength and physical function to evalu-
ate the willingness and ability of potential participants to 
comply with the study measures. As such, these additional 
measures are reported for a subgroup of 494 participants. 
Before screening, all participants signed informed consent 
and study protocols were approved by the ethical commit-
tee of Wageningen University.
Serum 25‑hydroxyvitamin D
Serum blood samples were collected during the screening 
visit and participants were instructed to remain fasted or 
take only a light meal. Samples were centrifuged, stored 
at − 80 °C and analyzed within one month after collec-
tion. Serum samples were analyzed using LC-MS/MS to 
measure total 25(OH)D concentration, which reflects the 
sum of serum 25(OH)D2 and 25(OH)D3. Samples col-
lected for the D-DOSE study (n = 259) were analyzed at 
the Endocrine Laboratory of the VU University Medical 
Centre, Amsterdam, The Netherlands [12]. The intra-assay 
and inter-assay coefficients of variation were below 6 and 
8%, respectively. Serum 25(OH)D samples collected for 
the D-FIT study (n = 497) were analyzed at the Depart-
ment of Clinical Chemistry, Canisius Wilhelmina Hospi-
tal, Nijmegen, The Netherlands. The intra-assay and inter-
assay coefficients of variation were below 4 and 7.5%, 
respectively [13]. Both laboratories are DEQAS-certified 
and the comparability of the LC-MS/MS methods between 
these two laboratories has been published previously, 
which indicated good agreement between methods [14].
Physical performance
Handgrip strength (HGS) was measured on the domi-
nant hand by taking the mean of three attempts (Jamar® 
hydraulic hand-held dynamometer, Patterson Medical, IL, 
USA). Mean gait speed was assessed by taking the aver-
age time, of two attempts, to walk a course of 15 feet. In a 
subgroup (n = 494), the Timed Up and Go test (TUG) and 
maximal isometric knee-extension strength were assessed. 
The TUG test is a test of functional ability to rise from a 
chair, walk 3 ms, make a turn, and walk back to the chair to 
sit down again. The average time to complete this test, out 
of two attempts, was recorded. Knee-extension strength 
was measured using the MicroFET hand-held dynamom-
eter (Hoggan Health Inc., West Jordan, UT, USA). Par-
ticipants were asked to sit upright with their knees in a 
90° angle. Maximal strength (Newton) was measured three 
times per leg with 5 s of muscle contraction and 60-s of 
rest between repetitions. The average muscle strength of 
the right leg was used for analysis. All measurements were 
performed by examiners trained to regularly perform these 
tests according to study protocol and standardized verbal 
encouragement was provided.
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Fried frailty criteria
Frailty status was assessed using the criteria published by 
Fried et al. [2]. These consist of five criteria as described in 
Table 1: unintentional weight loss (in the past year, by ques-
tionnaire), self-reported exhaustion (CES-D questionnaire) 
[15], weakness (handgrip strength), slow walking speed (gait 
speed), and low physical activity levels (Short version of 
the Minnesota questionnaire) [16]. According to the frailty 
definition of Fried et al., a participant scores non-frail when 
no criteria are present, pre-frail when one or two criteria are 
present and frail when three or more criteria are present [2].
Covariates
Questionnaires were used to record general participant char-
acteristics such as, age, sex, ethnicity (Caucasian, other), 
physical activity (short version of the Minnesota question-
naire) [16], vitamin D supplement use, smoking status, alco-
hol intake, and the number of chronic diseases (including 
heart failure, hypertension, diabetes mellitus, renal insuf-
ficiency, liver disease or cancer). A stadiometer was used 
to measure the height of the participants, and a calibrated 
analog scale was used to measure their weight. BMI was 
calculated as kg/m2. In addition, laboratory site and season 
of blood collection (winter: December–February, spring: 
March–May, summer: June–August, autumn: Septem-
ber–November) were recorded.
Statistical analyses
Characteristics of the study population are described 
as mean (SD), median (25th–75th percentile) or num-
ber (%) of categorical class. Serum 25(OH)D concentra-
tions < 50 nmol/L are generally considered deficient [8, 17], 
and a status between 50 and 75 or > 75 nmol/L is suggested 
for optimal muscle health and physical performance [18, 
19]. Serum 25(OH)D was categorized accordingly, with the 
latter (> 75 nmol/L) being the reference category. Differ-
ences between categories of serum 25(OH)D concentration 
were examined by one-way ANOVA for continuous vari-
ables, Kruskal–Wallis test in case of skewed variables and 
Chi-square tests for categorical variables. The association 
between serum 25(OH)D concentration and measures of 
physical performance (TUG and gait speed) and muscle 
strength (handgrip strength and knee-extension strength) 
were explored for nonlinearity by restricted cubic spline 
regression. As associations with TUG and hand grip strength 
tended to be nonlinear, all outcomes were further explored 
across categories of serum 25(OH)D. Multiple linear regres-
sion models were adjusted for factors known to be related 
to both serum 25(OH)D and physical performance. Model 
1 was adjusted for age, sex and laboratory site. Model 2 was 
additionally adjusted for BMI and season of blood collec-
tion, and model 3 was additionally adjusted for ethnicity, 
physical activity, alcohol intake, smoking and number of 
diseases. A Cox Proportional Hazards analysis with robust 
error variance was performed to calculate prevalence ratios 
(PR) of participants being pre-frail or frail across catego-
ries of serum 25(OH)D status. By assigning a constant risk 
period to all participants, the obtained hazard ratio can be 
considered a PR [20]. Models including frailty as depend-
ent variable were not corrected for physical activity, as this 
measure is also included in the definition of frailty status. 
Previous studies identified sex as a possible effect modifier 
in the association between vitamin D and physical perfor-
mance [21]. Therefore, interaction terms including sex were 
added to the final models. A P value of ≤ 0.1 was considered 
significant to retain an interaction term in the model. All 
analyses were performed using statistical software package 
Table 1  Diagnosis of frailty according to the Fried criteria [1]
Criterion Measured method Cut-offs by sex and height
Weight loss Unintentional weight loss Weight loss ≥ 4.5 kg in prior year
Grip strength Handgrip strength Men Women
  BMI ≤ 24 ≤ 29 kg   BMI ≤ 23 ≤ 17 kg
  BMI 24.1–26 ≤ 30 kg   BMI 23.1–26 ≤ 17.3 kg
  BMI 26.1–28 ≤ 30 kg   BMI 26.1–29 ≤ 18 kg
  BMI > 28 ≤ 32 kg   BMI > 29 ≤ 21 kg
Physical activity Short version of the Min-
nesota Questionnaire
Men Women
  ≤ 1.6 MJ   ≤ 1.1 MJ
Gait speed Gait speed
4.57-m course
Men Women
  Height ≤ 173 cm ≥ 7 s
  Height > 173 cm ≥ 6 s
  Height ≤ 159 cm ≥ 7 s
  Height > 159 cm ≥ 6 s
Self-reported exhaustion CES-D Depression Scale Participants scored positive if one of the following statements were present for 
≥ 3d/wk: (a) I felt that everything I did was an effort; (b) I could not get going
1176 European Journal of Nutrition (2019) 58:1173–1181
1 3
SAS version 9.2 (SAS Institute Inc., Cary, NC, USA) or 
using the R software package version 3.3.1 (R Foundation 
for Statistical Computing, Vienna, Austria). A two-sided P 
value of ≤ 0.05 was considered statistically significant.
Results
Table 2 shows the general characteristics of the study popu-
lation in total, and by categories of serum 25(OH)D status. 
The mean ± SD age of the study population was 74 ± 6 years 
and 55% were men. Mean BMI was 27.1 ± 3.5 kg/m2 and 
year-round median serum 25(OH)D status was 54 (38–72) 
nmol/L. Participants in the deficient serum 25(OH)D cat-
egory (< 50 nmol/L) were more likely to be men and more 
likely to have a higher BMI compared to participants in the 
higher categories of serum 25(OH)D status. Season of blood 
collection was significantly different between the vitamin D 
categories, with 81% of the vitamin D deficient participants 
measured in the winter/ spring. Of all participants, 12% 
reported to use a vitamin D supplement. A significant differ-
ence was observed in the number of supplement users across 
categories, with 4% in the deficient category and 18 and 19% 
in the two higher categories. Most participants scored non-
frail according to the Fried criteria, namely 57%, followed 
by 39% scoring pre-frail and 4% scoring frail.
Table 3 shows the association between serum 25(OH)
D concentration and measures of physical performance. 
There was an inverse association between serum 25(OH)D 
and TUG test scores, which remained significant after full 
adjustment for confounders. Compared with the reference 
category (> 75 nmol/L), participants with serum 25(OH)D 
concentrations < 50 nmol/L (β 0.73, 95% CI 0.14; 1.32) and 
50–75 nmol/L (β 0.83, 95% CI 0.21; 1.45) had significantly 
higher TUG scores, indicating more time needed to com-
plete the test. Likewise, participants with serum 25(OH)D 
status < 50 nmol/L (β − 0.04, 95% CI − 0.08; − 0.01) and 
status between 50 and 75 nmol/L (β − 0.04, 95% CI − 0.07; 
− 0.01) had significantly lower gait speed scores, compared 
with the reference category. Serum 25(OH)D categories 
were not associated with handgrip strength and knee-exten-
sion strength. The effect of vitamin D supplement use was 
explored by adjusting for this variable in the final model; 
however, this did not change the interpretation of results. 
Furthermore, interaction analyses did not suggest significant 
modification of the associations by sex.
Table 4 shows the association between serum 25(OH)D 
concentrations and frailty status. As only two participants 
scored frail in the > 75 nmol/L category, the 50–75 and 
> 75 nmol/L categories were combined to further explore 
the association between serum 25(OH)D and frailty status. 
Participants with serum 25(OH)D status < 50 nmol/L were 
about two times more likely to be frail (PR = 2.30, 95% CI 
1.11; 4.76, P = 0.02), compared to participants with serum 
25(OH)D status ≥ 50 nmol/L. The effect of vitamin D sup-
plement use was explored by adjusting for this variable in 
the final model. This attenuated the prevalence ratio, but the 
association remained significant (PR = 2.16, 95% CI 1.04; 
4.52, P = 0.04). When comparing non-frail vs. pre-frail older 
adults (or pre-frail and frail combined), no significant asso-
ciations were observed with serum 25(OH)D status.
Discussion
In this study, serum 25(OH)D concentrations were signifi-
cantly associated with physical performance and frailty sta-
tus in a population of community-dwelling older adults. To 
date, no generally accepted recommendation on the opti-
mal serum 25(OH)D status for muscle function is present, 
with the IOM proposing concentrations of 30–50 nmol/L 
for older adults [8], and others supporting thresholds of 
75 nmol/L or higher [18, 19]. Our results indicated that 
serum 25(OH)D status < 50 nmol/L, but also between 50 
and 75 nmol/L, were associated with lower functioning on 
TUG and gait speed tests, when compared to serum 25(OH)
D status > 75 nmol/L. Similar associations were observed in 
two large cohorts, where low serum 25(OH)D was associ-
ated with physical performance, and the strongest associa-
tions were observed on walking tests [22, 23]. In addition, 
comparable effect estimates were reported in a study of 
older adults at risk of disability, with slower walking speed 
(mean difference 0.04 m/s) in vitamin D deficient older 
adults (< 50 nmol/L) compared to those with a sufficient 
status [24]. The association with TUG was also observed 
in previous studies, where higher vitamin D concentrations 
were associated with a faster performance on the TUG test 
[21, 25]. In a study by van Dam et al., women with serum 
25(OH)D concentrations ≤ 80 nmol/L showed lower TUG 
scores (mean difference 0.77 s) than those who had a serum 
25(OH)D status ≥ 115 nmol/L, and the lower 25(OH)D cat-
egory appeared predictive of a greater decline in function 
over a period of 2.5 years [21]. In addition, several stud-
ies report an association between vitamin D deficiency and 
reduced handgrip strength [23, 26], or leg extension strength 
[27, 28], albeit not all [29]. In our study, no significant asso-
ciation was observed between serum 25(OH)D concentration 
and measures of muscle strength. Mechanistically, the link 
between vitamin D and muscle function is explained via the 
regulation of calcium and phosphate, necessary for muscle 
contraction, or via the activation of the vitamin D receptor 
(VDR) in muscle cells [30]. However, the presence of the 
VDR is also observed in neurons and glial cells in several 
regions of the brain, which suggests a role of vitamin D in 
the neuromuscular system [31, 32]. Vitamin D deficiency 
is associated with an increased postural sway and greater 
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Table 2  Participant 
characteristics
Values presented are mean ± SD or median (25th–75th percentile). Between-group differences explored by 
one-way ANOVA, Kruskal–Wallis test or Chi-square test
25(OH)D 25-hydroxyvitamin D, BMI Body Mass Index, VitD suppl. users vitamin D supplement users; 
TUG Timed Up and Go, HGS Hand grip strength, N Newton
a 3 missing values
b 5 missing values
c 6 missing values
d 1 missing value
e 7 missing values
f 4 missing values
g 9 missing values
h Assisted living includes: home care or service flat
i Winter–spring: Dec–May, summer–autumn: Jun–Nov











Men, n (%) 416 (55) 217 (64) 125 (49) 76 (46) < 0.01
Age, year 73.8 ± 6.4 74.1 ± 6.6 74.0 ± 6.2 72.9 ± 5.9 0.08
BMI, kg/m2 27.1 ± 3.5 27.5 ± 3.7 27.0 ± 3.3 26.2 ± 3.1 < 0.01
Caucasian, n (%) 736 (98) 327 (97) 250 (98) 159 (98) 0.49
Independent living, n (%)a,h 723 (96) 320 (95) 243 (96) 160 (99) 0.10
Non-smokers, n (%)a 705 (94) 311 (92) 239 (94) 155 (96) 0.31
Alcohol consumers, n (%)a 598 (79) 269 (80) 197 (78) 132 (82) 0.61
25(OH)D, nmol/L 54 (38–72) 36 (29–42) 62 (58–67) 91 (84–100) < 0.01
Calcium 2.24 (0.09) 2.24 (0.09) 2.25 (0.10) 2.24 (0.10) 0.43
VitD suppl. users, n (%)b 88 (12) 13 (4) 45 (18) 30 (19) < 0.01
Season, n (%)i
 Summer–autumn 259 (34) 64 (19) 101 (40) 94 (58) < 0.01
 Winter–spring 497 (66) 276 (81) 153 (60) 68 (42)
Number of diseases, n (%)c
 0 380 (51) 159 (47) 130 (52) 91 (56) 0.36
 1–2 353 (47) 167 (50) 117 (46) 69 (43)
 ≥ 3 17 (2) 10 (3) 5 (2) 2 (1)
Physical activity, MJ/weekd 8.4 (4.5–13.0) 7.8 (4.5–13.1) 8.5 (4.3–12.0) 9.6 (5.4–15.1) 0.11
TUG,  sj,d 9.8 ± 2.4 9.9 ± 2.5 9.9 ± 2.3 9.1 ± 2.2 0.04
Gait, m/se 1.06 ± 0.20 1.05 ± 0.21 1.05 ± 0.19 1.10 ± 0.20 0.03
Knee-extension,  Nj 328 ± 104 336 ± 103 324 ± 104 301 ± 106 0.04
HGS,  kgf 28.9 ± 9.5 29.4 ± 9.3 28.1 ± 9.6 28.9 ± 9.7 0.23
Frailty, n (%)g
 Non-frail 425 (57) 183 (55) 142 (57) 100 (62) 0.16
 Pre-frail 289 (39) 131 (39) 98 (39) 60 (37)
 Frail 33 (4) 20 (6) 11 (4) 2 (1)
Positive on frailty
 Weight loss, n (%) 23 (3) 14 (4) 5 (2) 4 (3) 0.28
 Exhaustion, n (%)a 115 (15) 51 (15) 41 (16) 23 (14) 0.86
 Physical activity, n (%)a 54 (7) 26 (8) 20 (8) 8 (5) 0.46
 HGS, n (%)a 213 (28) 102 (30) 76 (30) 35 (22) 0.10
 Gait, n (%)c 49 (7) 26 (8) 16 (6) 7 (4) 0.34
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risk of falling [33]. Moreover, a previous trial showed that 
vitamin D supplementation improved balance with 9% in 
vitamin D deficient older adults [34]. It is thus plausible that 
vitamin D status is more strongly associated with complex 
functional parameters rather than muscle strength due to its 
suggested role in neurological processes of motor perfor-
mance. However, more research is needed in this field.
Vitamin D deficient participants (< 50 nmol/L) were 
~ 2 times as likely to score frail, compared to those with 
sufficient serum 25(OH)D concentrations. This is in line 
with most previous studies investigating this association 
[9, 35, 36]. In the Longitudinal Aging Study Amsterdam 
(LASA), participants with 25(OH)D status between 25 and 
50 nmol/L were 1.7 times as likely to be frail, and those 
with serum status below 25 nmol/L were 2.6 times as likely 
to be frail compared to the reference group with vitamin 
D status > 50 nmol/L [37]. Likewise, in the NHANES III 
study, older adults with vitamin D deficiency (< 37 nmol/L) 
were 3.7 times as likely to score frail on the Fried criteria 
compared to the reference group (≥ 75 nmol/L) [11]. Also, 
pre-frail individuals are regarded as a suitable target group 
for intervention studies to prevent further functional decline 
[38]. In our study, serum 25(OH)D concentrations were not 
associated with the pre-frail state. While the prevalence 
of pre-frailty was higher than frailty, the non-significant 
findings might relate to the fact that the pre-frail state is 
a less distinct condition as only one or two Fried criterion 
need to be present to score positive on pre-frailty. Neverthe-
less, a prospective study reported that serum 25(OH)D sta-
tus ≥ 50 nmol/L tended to prevent a decline from the pre-frail 
to frail state over a period of 3 to 6 years [39], which might 
indicate that prevention of vitamin D deficiency is also rel-
evant in this stage. Furthermore, sex has been reported as 
an effect modifier in the association between 25(OH)D and 
frailty [40]. In our study, the prevalence of frailty was rela-
tively low (4%), limiting reliable testing of effect modifica-
tion across such a small sample of cases.
Overall, the association between vitamin D status and 
frailty appears to be consistent, with lower serum 25(OH)
D status associated with an increased likelihood of being 
frail. However, the causality of the association remains to 
be determined, given the cross-sectional design of these 
reported associations. An important determinant of vita-
min D status is sun exposure, which closely relates to 
being outdoors and physically active. As frail older adults 
might stay more indoors, reverse causation is plausible. 
Autier et al. recently discussed that the serum 25(OH)D 
status might not be a cause of adverse health outcomes, but 
a marker of ill health [41]. While we controlled for a broad 
range of lifestyle and health-related factors, correcting for 
Table 3  Association between 
serum 25-hydroxyvitamin D 
status and physical performance
Analyzed by multiple linear regression
Model 1 adjusted for age, sex and laboratory site, Model 2 adjusted for age, sex, laboratory site, BMI and 
season, Model 3 adjusted for age, sex, laboratory site, BMI, season, ethnicity, physical activity, alcohol, 
smoking and number of diseases, TUG Timed Up and Go, HGS Hand grip strength, N Newton
*P < 0.05
**P < 0.01
Serum 25-hydroxyvitamin D n
< 50 nmol/L 50–75 nmol/L > 75 nmol/L
β (95% CI) β (95% CI) Reference group
TUG, s
 Model 1 0.85 (0.24; 1.45)** 0.83 (0.19; 1.47)* 0 (ref) 493
 Model 2 0.77 (0.18; 1.36)* 0.84 (0.22; 1.47)** 0 (ref) 493
 Model 3 0.73 (0.14; 1.32)* 0.83 (0.21; 1.45)** 0 (ref) 488
Gait, m/s
 Model 1 − 0.06 (− 0.10; − 0.02)** − 0.05 (− 0.09; − 0.01)** 0 (ref) 749
 Model 2 − 0.05 (− 0.09; − 0.01)** − 0.04 (− 0.08; − 0.01)* 0 (ref) 749
 Model 3 − 0.04 (− 0.08; − 0.01)* − 0.04 (− 0.07; − 0.01)* 0 (ref) 745
HGS, kg
 Model 1 − 0.93 (− 2.25; 0.38) − 0.71 (− 2.02; 0.61) 0 (ref) 752
 Model 2 − 1.06 (− 2.38; 0.26) − 0.84 (− 2.15; 0.47) 0 (ref) 752
 Model 3 − 0.92 (− 2.25; 0.40) − 0.78 (− 2.10; 0.53) 0 (ref) 748
Knee-extension, N
 Model 1 7.74 (− 15.03; 30.50) 12.23 (− 11.95; 36.42) 0 (ref) 494
 Model 2 7.70 (− 15.10; 30.50) 13.09 (− 11.11; 37.29) 0 (ref) 494
 Model 3 9.89 (− 12.82; 32.60) 12.71 (− 11.37; 36.80) 0 (ref) 489
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confounding remains challenging. As we used question-
naires to estimate physical activity status and season to 
correct for sun exposure, residual confounding cannot 
be excluded. Besides the factors inherent to the cross-
sectional design of this study, other limitations should be 
noted. The prevalence of frailty was relatively low when 
compared to the reported prevalence of 10% for physical 
frailty in community-dwelling older adults [3]. The low 
prevalence might relate to the fact that this population 
consists of older adults that were willing to participate in 
an intervention trial and had likely a better health status 
or were more mobile compared to the general population, 
limiting the generalizability of the study findings. Also, 
parathyroid hormone (PTH), could potentially mediate the 
association between serum 25(OH)D status and physical 
performance or frailty, but was not measured in this study. 
Nevertheless, Pabst et al. investigated the mediating effect 
of PTH on frailty, but the attenuation of OR was small, 
suggesting an independent association with 25(OH)D [36]. 
Strengths of this study include the broad range of vitamin 
D concentrations measured in this population, the rela-
tively high prevalence of vitamin D deficiency, and the 
fact that, besides the measurement of frailty, we included 
measures of lower extremity strength and TUG to reflect 
overall body function and strength.
With only 12% of the participants using a vitamin D sup-
plement, 45% of our study population was vitamin D defi-
cient. Identifying older adults at risk of vitamin D deficiency 
might be important given the possible predisposed risk of 
frailty. In this study, associations were observed between 
25(OH)D status and the performance on the TUG and gait 
speed test. Both tests represent the ability of motor perfor-
mance and balance control, supporting the plausible modu-
latory role of vitamin D in fall prevention [42]. Although 
the observed associations represent only small clinically 
meaningful changes [43, 44], if causal, these findings might 
be relevant for public health.
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